Alan L Rothman Selected Research

Dengue (Dengue Fever)

1/2021	Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection.
1/2021	Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.
1/2021	Correlation between reported dengue illness history and seropositivity in rural Thailand.
1/2020	Heterogeneity of Dengue Illness in Community-Based Prospective Study, Iquitos, Peru.
1/2020	Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.
1/2020	Major Histocompatibility Complex Class I Chain-Related A and B (MICA and MICB) Gene, Allele, and Haplotype Associations With Dengue Infections in Ethnic Thais.
1/2019	Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand.
10/2018	Use of structural equation models to predict dengue illness phenotype.
1/2017	Immune-mediated cytokine storm and its role in severe dengue.
8/2016	State-of-the-art monitoring in treatment of dengue shock syndrome: a case series.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan L Rothman Research Topics

Disease

57	Infections 01/2021 - 05/2002
42	Dengue (Dengue Fever) 01/2021 - 05/2002
11	Severe Dengue 01/2017 - 05/2002
9	Coinfection 01/2019 - 04/2007
8	Virus Diseases (Viral Diseases) 03/2014 - 05/2002
3	Yellow Fever 02/2011 - 09/2009
3	Viremia 10/2008 - 05/2002
3	Vaccinia 10/2004 - 04/2002
2	Asymptomatic Infections 01/2019 - 12/2018
2	Convalescence 10/2016 - 01/2011
2	Human Influenza (Influenza) 08/2015 - 07/2013
2	Hepatitis C 01/2011 - 04/2006
2	Fibrosis (Cirrhosis) 01/2011 - 04/2006
2	Thrombocytopenia (Thrombopenia) 05/2006 - 05/2002
2	Smallpox (Variola) 04/2003 - 06/2002
1	Inflammation (Inflammations) 01/2021
1	Shock 08/2016
1	Fever (Fevers) 12/2013
1	Japanese Encephalitis 07/2010
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2009
1	Acute Disease 08/2009
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2008
1	Reinfection 09/2008
1	Hypersensitivity (Allergy) 08/2008
1	Injection Site Reaction 08/2008
1	Vasculitis (Vasculitides) 08/2008
1	Necrosis 07/2008
1	Melanoma (Melanoma, Malignant) 07/2008
1	Leptospirosis 12/2007

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 01/2021 - 04/2002
17	CytokinesIBA 01/2019 - 05/2002
15	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2002
11	EpitopesIBA 04/2020 - 06/2002
10	Neutralizing AntibodiesIBA 05/2016 - 03/2004
9	AntibodiesIBA 01/2021 - 03/2004
7	Dengue VaccinesIBA 01/2021 - 07/2011
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 05/2002
6	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2006
6	Peptides (Polypeptides)IBA 01/2021 - 06/2002
5	Immunoglobulin M (IgM)IBA 01/2021 - 12/2007
5	AntigensIBA 10/2016 - 06/2002
5	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2014 - 06/2002
5	Antiviral Agents (Antivirals)IBA 01/2011 - 04/2006
4	InterferonsIBA 04/2006 - 06/2002
3	Interferon-gamma (Interferon, gamma)IBA 04/2009 - 05/2002
3	Interleukin-8 (Interleukin 8)IBA 04/2006 - 06/2002
3	EnzymesIBA 10/2004 - 06/2002
2	Immunoglobulin G (IgG)IBA 01/2021 - 04/2020
2	IgG Receptors (Fc gamma RI)IBA 01/2021 - 08/2005
2	Immunoglobulin A (IgA)IBA 01/2021 - 04/2020
2	Interleukin-2 (IL2)IBA 01/2019 - 10/2009
2	Chemokine CCL5IBA 12/2018 - 09/2005
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2018 - 12/2007
2	HLA-A Antigens (HLA-A)IBA 01/2011 - 03/2006
2	ChemokinesIBA 10/2008 - 09/2005
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2008 - 06/2005
2	Transaminases (Aminotransferases)IBA 02/2008 - 05/2002
2	NF-kappa B (NF-kB)IBA 04/2006 - 09/2005
2	InterleukinsIBA 04/2006 - 05/2002
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	micaIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 12/2018
1	Interleukin-15 (Interleukin 15)IBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 12/2018
1	Interleukin-12 (IL 12)IBA 12/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2018
1	Serine (L-Serine)FDA Link 01/2017
1	Dynamins (Dynamin)IBA 01/2017
1	Immunoglobulin D (IgD)IBA 10/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2016
1	HLA-B44 AntigenIBA 09/2015
1	ProteomeIBA 09/2015
1	Viral RNAIBA 01/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2011
1	Yellow Fever Vaccine (Vaccine, Yellow Fever)FDA Link 07/2010
1	ChimeriVaxIBA 07/2010
1	Interleukin Receptor Common gamma SubunitIBA 10/2009
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 10/2009
1	Lymphotoxin-alpha (Lymphotoxin)IBA 05/2009
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2009
1	Messenger RNA (mRNA)IBA 04/2009
1	DNA (Deoxyribonucleic Acid)IBA 08/2008
1	Interferon Type IIBA 07/2008
1	Histocompatibility Antigens Class IIBA 07/2008
1	Galectin 3 (LGALS3)IBA 07/2008
1	Carrier Proteins (Binding Protein)IBA 07/2008
1	Factor VII (Proconvertin)IBA 07/2008
1	LigandsIBA 07/2008
1	Serum AlbuminIBA 12/2007
1	Immunoglobulins (Immunoglobulin)IBA 04/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2007
1	Cell Adhesion MoleculesIBA 09/2006
1	Interleukin-11 (Interleukin 11)IBA 05/2006
1	Thrombopoietin (c-mpl Ligand)IBA 05/2006
1	Biomarkers (Surrogate Marker)IBA 05/2006
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 04/2006
1	LuciferasesIBA 04/2006

Therapy/Procedure

1	Tourniquets 10/2018
1	Resuscitation 08/2016
1	Therapeutics 04/2006